LA ROCHE-POSAY Convenes "Blue Ribbon" Caring for Cancer Patients' Skin Health Summit
- Chaileedo Press
- May 25, 2022
- 2 min read
On the 16th "5.25 National Skin Care Day", LA ROCHE-POSAY joined hands with two authoritative experts from the Dermatologists Branch of the Chinese Medical Doctor Association (CMDA) and the Chinese Society of Clinical Oncology (CSCO) for the first time to open heart-healing for"love " LA ROCHE-POSAY "Blue Ribbon" Caring for Cancer Patients' Skin Adverse Skin Reaction Health Summit, which will be broadcast live on the Chinese medical community platform from 19:00 to 21:10, BST on May 25, 2022, and CHAILEEDO will synchronize in time The latest opinion content of the forum
As an active healthy skin care brand originating from France, LA ROCHE-POSAY launched the "Blue Ribbon" project to care for the skin health of cancer patients in 2022, aiming to appeal to more people to pay attention to the skin health problems of cancer patients during the treatment process. On the 16th "5.25 National Skin Care Day", LA ROCHE-POSAY joined hands with two authoritative experts from the Dermatologists Branch of the Chinese Medical Doctor Association (CMDA) and the Chinese Society of Clinical Oncology (CSCO) for the first time to open heart-healing for"love " LA ROCHE-POSAY "Blue Ribbon" Caring for Cancer Patients' Skin Adverse Skin Reaction Health Summit, hoping to guide the public to pay attention to the skin health problems of cancer patients and provide practical solutions to skin problems through interdisciplinary exchanges between dermatology and oncology, so as to further realize the grand vision of 'beauty and health'.
The live broadcast of the summit forum will be broadcast live on the platform of the Chinese medical community from 19:00 to 21:10, BST on May 25, 2022, and the official video number of LA ROCHE-POSAY will be broadcast simultaneously. This summit forum will realize the first cross-disciplinary linkage between dermatology and oncology in the Chinese industry. At the same time,LA ROCHE-POSAY will release the first "Investigation and Research Report on the Current Situation of Adverse Skin Reaction in Chinese Cancer Clinical Diagnosis and Treatment" in response to the cognition, opinion and current situation of Chinese oncology patients and clinicians on adverse skin reactions caused by treatment. Industry experts will analyze the survey results in depth in this summit forum, and discuss the importance of interdisciplinary collaboration in skin health management in tumor treatment through roundtable meetings with brand executives, so as to provide scientific nursing suggestions for adverse skin reactions.
Comments